Literature DB >> 8871157

Nerve growth factor delays retinal degeneration in C3H mice.

A Lambiase1, L Aloe.   

Abstract

BACKGROUND: The aim of the present study was to investigate the biological role of nerve growth factor (NGF) on retinal degeneration in the C3H mouse strain. This strain is characterized by a single gene mutation (rd) which leads to photoreceptor degeneration resembling human retinitis pigmentosa.
METHODS: Neural retinas from 1- to 25 day-old C3H mice were dissected from outer ocular tissues, dissociated in cell suspension, stained with a vital dye and counted in a hemocytometer. For in vivo study, NGF was injected into the intraocular or retro-ocular area, and at the end of the treatment the mice were killed. The eyes were enucleated, fixed and cut by cryostat into 14-microns serial sections. The serial sections were stained with hematoxylin-eosin and the outer nuclear layer (ONL) was measured using a computerized image analysis system.
RESULTS: An intraocular injection of NGF, or repeated retro-ocular injections, induced a significant increase in ONL thickness compared to controls.
CONCLUSION: Our data show that NGF inhibits retinal degeneration in C3H mice. The mechanism(s) underlying the protective action of NGF against retinal cell death remains to be established.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871157     DOI: 10.1007/bf02343055

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  38 in total

1.  Programmed cell death: the paths to suicide.

Authors:  J Altman
Journal:  Trends Neurosci       Date:  1992-08       Impact factor: 13.837

Review 2.  Social controls on cell survival and cell death.

Authors:  M C Raff
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

Review 3.  The nerve growth factor 35 years later.

Authors:  R Levi-Montalcini
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

4.  Selective failure of long-term survival of isolated photoreceptors from both homozygous and heterozygous rd (retinal degeneration) mice.

Authors:  L Politi; R Adler
Journal:  Exp Eye Res       Date:  1988-08       Impact factor: 3.467

5.  Survival of purified embryonic chick retinal ganglion cells in the presence of neurotrophic factors.

Authors:  D Lehwalder; P L Jeffrey; K Unsicker
Journal:  J Neurosci Res       Date:  1989-10       Impact factor: 4.164

6.  An immunohistochemical study of the nerve growth factor receptor in developing rats.

Authors:  Q Yan; E M Johnson
Journal:  J Neurosci       Date:  1988-09       Impact factor: 6.167

7.  Structure and developmental expression of the nerve growth factor receptor in the chicken central nervous system.

Authors:  T H Large; G Weskamp; J C Helder; M J Radeke; T P Misko; E M Shooter; L F Reichardt
Journal:  Neuron       Date:  1989-02       Impact factor: 17.173

8.  The death programme in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization.

Authors:  S N Edwards; A E Buckmaster; A M Tolkovsky
Journal:  J Neurochem       Date:  1991-12       Impact factor: 5.372

9.  Biological importance of the retrograde axonal transport of nerve growth factor in sensory neurons.

Authors:  M Goedert; K Stoeckel; U Otten
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

10.  Growth factor-induced cytosolic calcium ion transients in cultured human retinal pigment epithelial cells.

Authors:  S Kuriyama; T Ohuchi; N Yoshimura; Y Honda
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-10       Impact factor: 4.799

View more
  13 in total

Review 1.  [Survival factors in the treatment of hereditary retinal degeneration].

Authors:  R Frigg; A Wenzel; C Grimm; C E Remé
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

2.  Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension.

Authors:  A Lambiase; M Centofanti; A Micera; G L Manni; E Mattei; A De Gregorio; G de Feo; M G Bucci; L Aloe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-12       Impact factor: 3.117

3.  Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse.

Authors:  M Cayouette; D Behn; M Sendtner; P Lachapelle; C Gravel
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

4.  Nerve growth factor (NGF) and lenses: effects of NGF in an in vitro rat model of cataract.

Authors:  Emiliano Ghinelli; Luigi Aloe; Magdalena Cortes; Alessandra Micera; Alessandro Lambiase; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-09-09       Impact factor: 3.117

5.  Regenerative therapy for retinal disorders.

Authors:  Narsis Daftarian; Sahar Kiani; Azadeh Zahabi
Journal:  J Ophthalmic Vis Res       Date:  2010-10

6.  Effect of purified murine NGF on isolated photoreceptors of a rodent developing retinitis pigmentosa.

Authors:  Maria Luisa Rocco; Bijorn Omar Balzamino; Pamela Petrocchi Passeri; Alessandra Micera; Luigi Aloe
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 7.  Recent advances of stem cell therapy for retinitis pigmentosa.

Authors:  Yuxi He; Yan Zhang; Xin Liu; Emma Ghazaryan; Ying Li; Jianan Xie; Guanfang Su
Journal:  Int J Mol Sci       Date:  2014-08-20       Impact factor: 5.923

Review 8.  Nerve growth factor: from the early discoveries to the potential clinical use.

Authors:  Luigi Aloe; Maria Luisa Rocco; Patrizia Bianchi; Luigi Manni
Journal:  J Transl Med       Date:  2012-11-29       Impact factor: 5.531

9.  Vasoregression linked to neuronal damage in the rat with defect of polycystin-2.

Authors:  Yuxi Feng; Yumei Wang; Oliver Stock; Frederick Pfister; Naoyuki Tanimoto; Mathias W Seeliger; Jan-Luuk Hillebrands; Sigrid Hoffmann; Hartwig Wolburg; Norbert Gretz; Hans-Peter Hammes
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

10.  Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial.

Authors:  Mauro P Ferrari; Flavio Mantelli; Marta Sacchetti; Maria Irene Antonangeli; Franca Cattani; Gaetano D'Anniballe; Francesco Sinigaglia; Pier Adelchi Ruffini; Alessandro Lambiase
Journal:  BioDrugs       Date:  2014-06       Impact factor: 5.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.